Accolade, Inc. Stock Price, News & Analysis

Accolade, Inc. (NASDAQ: ACCD) announced its participation in several upcoming investor conferences. Key events include the 41st Annual William Blair Growth Stock Conference on June 2, 2021, the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8, 2021, and the Stifel 2021 Virtual Cross Sector Insight Conference on June 10, 2021. Each session will feature a fireside chat or presentation, providing insights into the company's innovative healthcare solutions aimed at improving health outcomes and reducing costs. For more details, visit ir.accolade.com.

Accolade, Inc. (NASDAQ: ACCD) will participate in two major investor conferences. The first is the Bank of America 2021 Health Care Conference on May 12, 2021, featuring a presentation at 8:45 a.m. E.T. The second event is the 16th Annual Needham Virtual Technology & Media Conference on May 20, 2021, which will include a fireside chat at 8:00 a.m. E.T. Accolade specializes in personalized health and benefit solutions that help individuals navigate the healthcare system, achieving high consumer satisfaction ratings over 90 percent.

Accolade (NASDAQ: ACCD) reported a 33% increase in fiscal Q4 2021 revenue to $59.2 million and a 29% rise in fiscal year 2021 revenue, reaching $170.4 million. The company anticipates fiscal year 2022 revenue between $260 million and $265 million, with adjusted EBITDA projected between $(38) million and $(42) million. The acquisition of 2nd.MD and the proposed acquisition of PlushCare will expand Accolade's addressable market to over $200 billion. The company also increased its Annual Contract Value by 31% to $211 million and doubled its customer base to 112.

Accolade reported a fiscal fourth quarter 2021 revenue of $59.2 million, up 33% from $44.4 million in the same quarter of 2020. For the fiscal year 2021, revenues reached $170.4 million, a 29% increase year-over-year. The company initiated guidance for fiscal 2022 revenue between $260 million and $265 million, with an expected Adjusted EBITDA loss of $(38) million to $(42) million. Recent acquisitions of 2nd.MD and planned acquisition of PlushCare aim to expand Accolade's addressable market to over $200 billion.

Accolade, Inc. (Nasdaq: ACCD) has announced its acquisition of PlushCare, a leader in virtual primary care and mental health services. This transaction will enable Accolade to enhance its healthcare offerings, directly providing virtual consultations to its members. With a combined addressable market exceeding $200 billion, this acquisition aims to improve health outcomes and reduce costs. The deal is expected to be accretive to Accolade’s growth, leveraging its existing engagement platforms and operational efficiencies. The total transaction value is up to $450 million, with the closing anticipated in June 2021.

Accolade, Inc. (NASDAQ: ACCD) is set to release its fiscal fourth quarter and full year 2021 financial results on May 5, 2021, after market close. A conference call will follow at 4:30 p.m. E.T. for detailed insights into the performance. Accolade offers tailored, technology-driven health solutions, aiming to navigate and optimize healthcare and workplace benefits for users, achieving over 90% consumer satisfaction ratings. Investors can access the call via phone or online, with a replay available for 90 days post-event.

Accolade, Inc. (Nasdaq: ACCD) has announced the pricing of $250 million in 0.50% convertible senior notes due 2026. The private placement is aimed at qualified institutional buyers under Rule 144A of the Securities Act. The initial conversion rate is set at 19.8088 shares per $1,000 principal amount, equating to a conversion price of $50.48 per share, reflecting a 32.5% premium over the last stock price. Proceeds are expected to be approximately $242.4 million and will be utilized for corporate purposes including capital expenditures and acquisitions. The offering closes on March 29, 2021.

Accolade, Inc. (ACCD) reported preliminary financial results for the fiscal year 2021, projecting Q4 revenue between $56.9 million and $57.9 million, and annual revenue between $168.0 million and $169.0 million. The net loss for Q4 is expected to be between $(7.1) million and $(5.6) million, with an annual net loss of $(53.0) million to $(51.5) million. Adjusted EBITDA for Q4 is projected between $0.6 million and $2.1 million, while the annual adjusted EBITDA is expected between $(29.0) million and $(27.5) million. Full results are due on May 5, 2021.

Accolade, Inc. (Nasdaq: ACCD) announced plans to offer $250 million in convertible senior notes due 2026 in a private placement. The offering aims to provide funds for corporate purposes, including working capital and strategic investments. An additional $37.5 million may be purchased by initial buyers. The notes will be unsecured, with interest accruing semiannually. Capped call transactions are intended to mitigate potential dilution from conversions. The offering is subject to market conditions and has not been registered under the Securities Act.